BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6790440)

  • 1. Identification of the active precipitin components in a purified preparation of the A antigen of Blastomyces dermatitidis.
    Young KD; Larsh HW
    Infect Immun; 1981 Jul; 33(1):171-7. PubMed ID: 6790440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Western immunoblot analysis and serologic characterization of Blastomyces dermatitidis yeast form extracellular antigens.
    Hurst SF; Kaufman L
    J Clin Microbiol; 1992 Dec; 30(12):3043-9. PubMed ID: 1452683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of a purified skin test antigen from Blastomyces dermatitidis yeast-phase cell wall.
    Lancaster MV; Sprouse RF
    Infect Immun; 1976 Sep; 14(3):623-5. PubMed ID: 965086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of the major antigen WI-1 from Blastomyces dermatitidis yeasts and immunological comparison with A antigen.
    Klein BS; Jones JM
    Infect Immun; 1994 Sep; 62(9):3890-900. PubMed ID: 7520423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and characterization of a hybridoma-derived antibody to Blastomyces dermatitidis.
    Young KD; Larsh HW
    J Clin Microbiol; 1982 Feb; 15(2):204-7. PubMed ID: 7068817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of two Blastomyces dermatitidis serotypes by exoantigen analysis.
    Kaufman L; Standard PG; Weeks RJ; Padhye AA
    J Clin Microbiol; 1983 Jul; 18(1):110-4. PubMed ID: 6411760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yeast- and mycelial-phase antigens of Blastomyces dermatitidis: comparison using disc gel electrophoresis.
    Cox RA; Larsh HW
    Infect Immun; 1974 Jul; 10(1):48-53. PubMed ID: 4135463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of reference antisera for laboratory diagnosis of blastomycosis.
    Green JH; Harrell WK; Johnson JE; Benson R
    J Clin Microbiol; 1979 Jul; 10(1):1-7. PubMed ID: 115894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine antibody response to Blastomyces dermatitidis WI-1 antigen.
    Klein BS; Squires RA; Lloyd JK; Ruge DR; Legendre AM
    Am J Vet Res; 2000 May; 61(5):554-8. PubMed ID: 10803652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Blastomyces dermatitidis antigen in patients with newly diagnosed blastomycosis.
    Bariola JR; Hage CA; Durkin M; Bensadoun E; Gubbins PO; Wheat LJ; Bradsher RW
    Diagn Microbiol Infect Dis; 2011 Feb; 69(2):187-91. PubMed ID: 21251563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and ELISA evaluation of Blastomyces dermatitidis yeast phase lysate antigens.
    Johnson SM; Scalarone GM
    Diagn Microbiol Infect Dis; 1988 Oct; 11(2):81-6. PubMed ID: 3229098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blastomyces dermatitidis Antibody and Antigen Detection: Comparison of Four Lysate Antigens and Antibodies Prepared from Human Isolates from a Blastomycosis Outbreak.
    Hammon JT; Kennell BC; Scalarone GM
    Mycopathologia; 2019 Oct; 184(5):661-666. PubMed ID: 31583528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WI-1, a novel 120-kilodalton surface protein on Blastomyces dermatitidis yeast cells, is a target antigen of cell-mediated immunity in human blastomycosis.
    Klein BS; Sondel PM; Jones JM
    Infect Immun; 1992 Oct; 60(10):4291-300. PubMed ID: 1383148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoelectric focusing and ELISA evaluation of a Blastomyces dermatitidis human isolate.
    Shurley JF; Scalarone GM
    Mycopathologia; 2007 Aug; 164(2):73-6. PubMed ID: 17578679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation, purification, and radiolabeling of a novel 120-kD surface protein on Blastomyces dermatitidis yeasts to detect antibody in infected patients.
    Klein BS; Jones JM
    J Clin Invest; 1990 Jan; 85(1):152-61. PubMed ID: 2295693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic recognition of a 25-amino acid repeat arrayed in tandem on a major antigen of Blastomyces dermatitidis.
    Klein BS; Hogan LH; Jones JM
    J Clin Invest; 1993 Jul; 92(1):330-7. PubMed ID: 8326001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigens and chemical composition of Blastomyces dermatitidis.
    Young KD; Larsh HW
    Mycopathologia; 1982 Apr; 78(1):47-63. PubMed ID: 7048101
    [No Abstract]   [Full Text] [Related]  

  • 18. Reliability of exoantigens for differentiating Blastomyces dermatitidis and Histoplasma capsulatum from Chrysosporium and geomyces species.
    Sekhon AS; Standard PG; Kaufman L; Garg AK
    Diagn Microbiol Infect Dis; 1986 Mar; 4(3):215-21. PubMed ID: 3956141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a highly sensitive and specific blastomycosis antibody enzyme immunoassay using Blastomyces dermatitidis surface protein BAD-1.
    Richer SM; Smedema ML; Durkin MM; Brandhorst TT; Hage CA; Connolly PA; Leland DS; Davis TE; Klein BS; Wheat LJ
    Clin Vaccine Immunol; 2014 Feb; 21(2):143-6. PubMed ID: 24285817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the enzyme immunoassay, immunodiffusion, and complement fixation tests in detecting antibody in human serum to the A antigen of Blastomyces dermatitidis.
    Klein BS; Kuritsky JN; Chappell WA; Kaufman L; Green J; Davies SF; Williams JE; Sarosi GA
    Am Rev Respir Dis; 1986 Jan; 133(1):144-8. PubMed ID: 3079974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.